Table 1. Immunosuppression combinations and target levels.
period after HTx | TAC/MMF | SIR/MMF | EVE/MMF | TAC/SIR | TAC/EVE | |||||
---|---|---|---|---|---|---|---|---|---|---|
Month 1–3 | 10–12 | 1.5–4 | 12–15 | 1.5–4 | 10–12 | 1.5–4 | 5–8 | 5–8 | 5–8 | 5–8 |
Month 4–12 | 8–10 | 1.5–4 | 10–12 | 1.5–4 | 8–10 | 1.5–4 | 5–8 | 5–8 | 5–8 | 5–8 |
TAC = tacrolimus; MMF = mycophenolate mofetil; SIR = sirolimus; EVE = everolimus, plasma concentrations in ng/ml